Quick answers
- What is Torsemide used for?
- The FDA-approved label (Torsemide, Remedyrepack Inc., August 27, 2026) says: “Torsemide is a loop diuretic indicated for: the treatment of edema associated with heart failure, renal disease or hepatic disease. the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Torsemide have a boxed warning?
- No. None of the 33 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Torsemide?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Torsemide been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Torsemide?
- 21 companies list prescription products of Torsemide in the FDA NDC Directory, including Bryant Ranch Prepack, AvKARE and A-S Medication Solutions.
What Torsemide is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Torsemide is a loop diuretic indicated for: the treatment of edema associated with heart failure, renal disease or hepatic disease. the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. …
— FDA label: Torsemide, Remedyrepack Inc., effective August 27, 2026. Read the full label on DailyMed →
The FDA has 33 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Conditions named on the label
These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.
Related medical specialties
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 33 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Tablet · Tablet, film coated |
|---|---|
| Route | Oral |
| Prescription products | 62 in the FDA NDC Directory |
| Brand names | Soaanz |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| torsemide 10 mg tablet | Generic | $0.0635 per tablet |
| torsemide 100 mg tablet | Generic | $0.1701 per tablet |
| torsemide 20 mg tablet | Generic | $0.0621 per tablet |
| torsemide 5 mg tablet | Generic | $0.0552 per tablet |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Bryant Ranch Prepack6 products
- AvKARE4 products
- A-S Medication Solutions4 products
- Rising Pharma Holdings, Inc.4 products
- Teva Pharmaceuticals USA, Inc.4 products
- AvPAK4 products
- Aurobindo Pharma Limited4 products
- XLCare Pharmaceuticals, Inc.4 products
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.4 products
- Camber Pharmaceuticals, Inc.4 products
- Chartwell RX, LLC4 products
- Golden State Medical Supply, Inc.4 products
- Aphena Pharma Solutions - Tennessee, LLC2 products
- Remedyrepack Inc.2 products
- NCS HealthCare of KY, LLC dba Vangard Labs2 products
- Sarfez Pharmaceuticals Inc1 product
- Redpharm Drug1 product
- Major Pharmaceuticals1 product
- American Health Packaging1 product
- Direct_Rx1 product
- Hikma Pharmaceuticals USA Inc.1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA213218 SOAANZ | Sarfe Pharms | June 14, 2021 | 1, latest November 17, 2021 2021: Manufacturing (CMC) |
Generic approvals (5)
- ANDA076346Pliva Pharm Ind · May 30, 2003
- ANDA076943Hikma · March 1, 2005
- ANDA076894Heritage · May 31, 2005
- ANDA078249Aurobindo Pharma · October 17, 2007
- ANDA079234Hetero Labs Ltd III · January 27, 2009
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Torsemide, Remedyrepack Inc., effective August 27, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →